Skip to main content
. 2010 Jan 5;102(2):301–315. doi: 10.1038/sj.bjc.6605498

Figure 3.

Figure 3

Study-level meta-analyses of venous-thromboembolic event (VTE) risk in 44 controlled studies carried out in the settings of chemotherapy, anaemia of cancer (AoC) or radiotherapy only. This analysis included 13 196 patients with 7237 ESA-treated patients and 5959 control patients.